Cyngn Inc. 10-Q Summary
Business Context and Reporting Period
Cyngn develops autonomous-driving software for industrial vehicles, including DriveMod, Cyngn Insight and Cyngn Evolve. The company is targeting industrial autonomy deployments and expects revenue from project-based deployments and recurring software subscriptions. The Enterprise Autonomy Suite was still under development and was not yet commercially available as of June 30, 2022.
This unaudited quarterly report covers the three and six months ended June 30, 2022, with comparisons to the corresponding 2021 periods. Cyngn is a non-accelerated filer, smaller reporting company and emerging growth company.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2022 | Six Months Ended June 30, 2022 | Comparable 2021 Period |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Research and development expense | $2.3 million | $3.9 million | $0.8 million and $1.8 million, respectively |
| General and administrative expense | $2.4 million | $4.5 million | $1.3 million and $1.9 million, respectively |
| Total operating expenses | $4.6 million | $8.4 million | $2.1 million and $3.6 million, respectively |
| Net loss | $4.6 million | $8.4 million | $2.1 million and $3.6 million, respectively |
| Net loss per share | $0.15 | $0.29 | $2.20 and $3.83, respectively |
| Net cash used in operating activities | Not provided for the quarter | $7.0 million | $3.5 million |
Because revenue was zero, gross profit and operating margins were not meaningful. The company reported an accumulated deficit of $124.9 million at June 30, 2022, compared with $116.5 million at December 31, 2021.
Balance Sheet, Cash Flow, Debt and Liquidity
- Cash and cash equivalents were $5.6 million at June 30, 2022, down from $21.9 million at December 31, 2021.
- Short-term investments were $27.0 million at June 30, 2022, consisting primarily of U.S. government treasury securities; total cash, restricted cash and short-term investments were approximately $32.6 million at fair value.
- Net cash used in operating activities was $7.0 million for the first six months of 2022, compared with $3.5 million in the prior-year period.
- Net cash used in investing activities was $27.6 million, including $27.0 million invested in short-term securities, approximately $0.4 million in property and equipment, and approximately $0.2 million for an intangible asset.
- Financing activities provided $18.2 million, principally from the April 2022 private placement and stock-option exercises.
- Total liabilities were $1.3 million, consisting primarily of operating lease liabilities. The filing reports no outstanding balance under the forgiven PPP loans and no other material debt.
- The company had $33.3 million of stockholders’ equity at June 30, 2022.
Material Changes Versus the Prior Comparable Period
- Revenue remained zero in both the quarter and first six months of 2022.
- Second-quarter research and development expense increased 171% to $2.3 million; first-half expense increased 123% to $3.9 million. Management attributed the increases to higher engineering headcount, external contractors, occupancy and travel costs.
- Second-quarter general and administrative expense increased 87% to $2.4 million; first-half expense increased 139% to $4.5 million. Drivers included higher personnel and stock-based compensation, expanded office space, directors’ and officers’ insurance, and public-company compliance costs.
- First-half net loss increased to $8.4 million from $3.6 million, while operating cash burn increased to $7.0 million from $3.5 million.
- Cyngn completed a private placement on April 29, 2022, issuing 3,790,322 common shares and 2,661,291 pre-funded warrants, all of which were exercised by May 2022. Net proceeds were approximately $18.1 million. The offering also included 6,451,613 common warrants exercisable at $2.98 per share through April 2027.
- Shares outstanding increased to 33.6 million at June 30, 2022 from 26.5 million at December 31, 2021, before considering potential dilution from warrants, options and restricted stock units.
Guidance, Outlook, Risks and Unusual Items
- Management expects limited paid pilot deployments in 2022 and 2023, with scaled deployments targeted to begin in 2024.
- The company expects annual research and development spending in the foreseeable future to equal or exceed 2020 and 2021 levels and expects research and development costs to increase over time.
- Management stated that the company has incurred operating losses since inception and must increase revenue, control expenses and obtain additional financing or other capital to achieve positive operating cash flow.
- Management concluded that existing cash, short-term investments and projected financing activities should fund operations and payment obligations for at least one year from the report issuance date, and the financial statements were prepared on a going-concern basis.
- Notable items included the $100,000 acquisition of exclusive intellectual-property rights, the renewal of the Menlo Park office lease through August 2023, and $1.2 million of stock-based compensation for the first six months.
- As of June 30, 2022, the company had 9.5 million outstanding stock options, 0.2 million unvested restricted stock units and 6.6 million outstanding warrants, creating substantial potential dilution.
- Risks identified include continued losses and dependence on external financing, execution and commercialization risk, inflation, rising interest rates, supply-chain and capital-market disruption related to the Russia-Ukraine conflict, cyberattacks, pandemics and other events beyond the company’s control.
- Management reported that disclosure controls and procedures were not effective because of a material weakness involving ineffective oversight of third parties assisting with financial reporting and disclosure. Remediation was in process, but effectiveness was not assured.
- The filing reports no material pending litigation and no material changes to the risk factors disclosed in the 2021 Form 10-K.
Important Facts for Investors to Verify
- Confirm the company’s cash runway using operating cash burn, investment maturities, projected financing needs and the timing of potential commercial revenue.
- Track progress toward marketing the Enterprise Autonomy Suite in 2022, pilot deployments in 2022–2023 and scaled deployments targeted for 2024.
- Evaluate whether zero revenue continues and whether paid pilots convert into recurring software subscriptions.
- Assess the dilution risk from 6.6 million warrants, 9.5 million options, restricted stock units and any future equity financing.
- Monitor remediation of the material weakness in internal controls and whether subsequent filings conclude that disclosure controls are effective.
- Reconcile the weighted-average share figures: the statement of operations reports 28,682,245 weighted-average shares for the six months ended June 30, 2022, while the notes report 26,682,245. The filing text does not provide a clear explanation for this discrepancy.